Hasil Pencarian (1)
small molecule | CAS: 2152628-33-4
Selpercatinib is a kinase inhibitor with enhanced specificity for RET tyrosine kinase receptors (RTKs) over other RTK classes.[A202055, A202052, L13604] Enhanced RET (Rearranged during transfection) oncogene expression is a hallmark of many cancers. Although …
Kategori:
Agents that produce hypertensionAntineoplastic AgentsAntineoplastic and Immunomodulating Agents
+19
Target Protein:
Proto-oncogene tyrosine-protein kinase receptor RetVascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 3
+3
Waktu ParuhSelpercatinib has a…
Vol. DistribusiSelpercatinib has a…
KlirensSelpercatinib has a…
Genetik
-